GODAVARIB — Godavari Biorefineries Balance Sheet
0.000.00%
- IN₹13.84bn
- IN₹18.61bn
- IN₹18.70bn
- 60
- 54
- 71
- 70
Annual balance sheet for Godavari Biorefineries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 138 | 100 | 213 | 111 | 123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,047 | 2,055 | 2,448 | 2,215 | 1,701 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,027 | 9,794 | 8,243 | 10,765 | 10,233 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,163 | 7,106 | 8,738 | 8,654 | 8,837 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,417 | 17,335 | 17,435 | 19,917 | 19,551 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,498 | 9,189 | 7,684 | 11,097 | 8,843 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,878 | 12,605 | 12,541 | 14,910 | 11,731 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,539 | 4,730 | 4,894 | 5,007 | 7,820 |
| Total Liabilities & Shareholders' Equity | 14,417 | 17,335 | 17,435 | 19,917 | 19,551 |
| Total Common Shares Outstanding |